 Nanotechnology has the potential to circumvent several drawbacks of conventional therapeutic formulations. Taylor made nanomaterials functionalized with specific ligands can target cancer cells in a predictable manner and deliver encapsulated payloads effectively. Nanotechnology will provide next generation platforms for cancer management and anti-cancer therapy. This article was authored by P. N. Navya, Anubhav Khaful, S. P. Srinivas and others.